Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

TCP-10c Inhibitors

TCP-10c inhibitors are a class of chemical compounds that function by selectively interacting with a specific biological target, known as TCP-10c. This target is typically a protein or enzyme that plays a critical role in certain biochemical pathways within cells. The inhibitors are designed to bind to the TCP-10c with high specificity, meaning they ideally do not interact with other molecules or proteins within the biological system. This selective binding can result in the modulation of the activity of TCP-10c, which can have various downstream effects on cellular processes. The precise mechanism of action of TCP-10c inhibitors depends on the nature of the protein they target and the manner in which they interact with it, which can include altering the protein's conformation, blocking its active site, or interfering with its ability to interact with other cellular components.

The design and development of TCP-10c inhibitors involve detailed knowledge of the structure and function of the target protein. Advanced techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and cryo-electron microscopy may be used to determine the three-dimensional structure of TCP-10c. With this information, chemists can utilize structure-based drug design to create molecules that fit precisely into the active site or other relevant regions of the protein. Additionally, the pharmacokinetic properties of TCP-10c inhibitors are of significant interest in their development, as these properties determine how the compound behaves within the biological system. Parameters such as solubility, stability, half-life, and metabolic pathways are critical factors in the design of these inhibitors, and they are typically optimized to ensure that the compounds are effective in their selective inhibition of TCP-10c.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Imatinib is a tyrosine kinase inhibitor targeting BCR-ABL, c-KIT, and PDGFR. By inhibiting these kinases, it may affect several signaling pathways and potentially decrease the activity of TCP-10c if it is influenced by these pathways.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$153.00
$356.00
15
(1)

ZM447439 is an Aurora kinase inhibitor that disrupts mitotic processes and checkpoints. Inhibition of Aurora kinase activity could indirectly reduce the activity of TCP-10c if it plays a role in cell cycle regulation.